Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC006486.9 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | AC007192.4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | AC007906.1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | AC008074.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | AC009065.1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | AC009133.23 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | AC011155.1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | AC011530.4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AC013264.1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | AC015688.3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |